Dr. Genadry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Bldg 129
Boston, MA 02115Phone+1 919-884-0704Fax+1 617-730-0335
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Emergency Medicine (Pediatrics), 2021- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2018 - 2021
Duke University HospitalPost-Doctoral Fellowship, Pediatric Hematology/Oncology, 2017 - 2018
American University of Beirut Faculty of MedicineClass of 2017
Certifications & Licensure
MA State Medical License 2018 - 2025- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 18 citationsThe Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma TumorigenesisMichael D. Deel, Katherine K. Slemmons, Ashley Hinson, Katia C. Genadry, Breanne A. Burgess
Clinical Cancer Research. 2018-03-07 - 36 citationsSoft Tissue Sarcoma Cancer Stem Cells: An Overview.Katia C. Genadry, Silvia Pietrobono, Rossella Rota, Corinne M. Linardic
Frontiers in Oncology. 2018-10-26 - 3 citationsA method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and Notch signaling.Katherine K Slemmons, Michael D Deel, Yi-Tzu Lin, Kristianne M Oristian, Nina Kuprasertkul
Biology Open. 2021-02-09
Journal Articles
- Soft Tissue Sarcoma Cancer Stem Cells: An OverviewCorinne M Linardic, Katia C Genadry, Frontiers in Neurology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
